Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Comment by 2b7f6fabon Sep 01, 2017 1:42pm
116 Views
Post# 26648159

RE:RE:Dr. Lilge's upcoming paper confirms Dr. Frost's implication

RE:RE:Dr. Lilge's upcoming paper confirms Dr. Frost's implicationNine zeroes to the right of the decimal $0.0000000001 . Or nine zeroes to the left- $1,000,000,000.
LaserStock29 wrote: Long as Roger remembers it's 9 zeros not 8  and that's 9 zeros to the right of the decimal point :-)

Then we'll be ok.. 

bencro wrote: I officially confirm that Dr. Frost opened some doors for Theralase/UHN.

Dr. Frost is the intelligent money partner we needed back in 2015.  It now pays off and this study confirms that, with Dr. Lilge now being on it with prostate and brain indications.  

Remember that subtile sentence in the March 2015 news release:  

... these funds are considered strategic to the Company as it has now solidified relationships with influential Canadian and US institutional investors that will prove to be invaluable down the road, as the Company executes on its strategic initiatives.  

And this one, knowing that Dr. Frost owns Ladenburg Thalmann:  

... Ladenburg Thalmann acted as exclusive U.S. placement agent in connection with the Offering.


Dr. Frost will help maximize TLT's valuation and will bring TLT to a position where PDT/PDC will displace major auto-immune therapy markets because of higher efficacy, less toxicity, shorter treatment time and lower costs, to a point where big pharmas won't have any more choices.

Having a potent PDC and developing precision automated dosimetry tools, TLT will grow into a multiple B$$$ market valuation company with dominent position in major late stage cancer indications:

- NMIBC
- Brain
- Lung
- Prostate
- Melanoma
- etc ...








Bullboard Posts